J. Rosen

发表

The search for safer glucocorticoid receptor ligands.

Jeffrey N Miner, J. Rosen, J. Miner, 2005, Endocrine reviews.

LGD-5552, an antiinflammatory glucocorticoid receptor ligand with reduced side effects, in vivo.

M. D. Leibowitz, L. De Grandpré, B. Bebo, 2008, Endocrinology.

trans-Activation and repression properties of the novel nonsteroid glucocorticoid receptor ligand 2,5-dihydro-9-hydroxy-10-methoxy-2,2,4-trimethyl-5-(1-methylcyclohexen-3-y1)-1H-[1]benzopyrano[3,4-f]quinoline (A276575) and its four stereoisomers.

M. Nakane, J. Kuk, G. Carter, 2002, Molecular pharmacology.

A nonsteroidal glucocorticoid receptor antagonist.

M. Nakane, J. Rosen, J. Miner, 2003, Molecular endocrinology.

Antiinflammatory glucocorticoid receptor ligand with reduced side effects exhibits an altered protein–protein interaction profile

E. Vajda, J. Rosen, J. Miner, 2007, Proceedings of the National Academy of Sciences.

Cell-Specific Activation of the Human Skeletal (cid:1) -Actin by Androgens

Hong Sun, William Y. Chang, J. Rosen, 2008 .

An orally active selective androgen receptor modulator is efficacious on bone, muscle, and sex function with reduced impact on prostate.

Russell Turner, William Schrader, R. Turner, 2007, Endocrinology.

CT‐1501R SELECTIVELY INHIBITS INDUCED INFLAMMATORY MONOKINES IN HUMAN WHOLE BLOOD EX VIVO

G. Rice, J. Bianco, J. Singer, 1994, Shock.

A novel antiinflammatory maintains glucocorticoid efficacy with reduced side effects.

M. Nakane, S. Elmore, R. Turner, 2003, Molecular endocrinology.

Determinants of promoter-specific activity by glucocorticoid receptor.

R. Stein, J. Rosen, J. Miner, 1996, Molecular endocrinology.

Cell-Specific Activation of the Human Skeletal α-Actin by Androgens

Hong Sun, William Y. Chang, J. Rosen, 2008 .

Sexual differentiation of the spinal nucleus of the bulbocavernosus is not mediated solely by androgen receptors in muscle fibers.

S. Fernando, William Y. Chang, L. Niel, 2009, Endocrinology.

Novel, non-steroidal, selective androgen receptor modulators (SARMs) with anabolic activity in bone and muscle and improved safety profile.

J. Rosen, A. Negro-Vilar, J Rosen, 2002, Journal of musculoskeletal & neuronal interactions.

Glucocorticoid Drugs, Evolution of

J. Rosen, J. Miner, C. Larson, 2003 .

A Non-Steroidal, Glucocorticoid Receptor Antagonist

M. Nakane, J. Rosen, J. Miner, 2003, Molecular endocrinology.